Le Lézard
Classified in: Health
Subjects: LAW, HSP, BLK

Health Affairs Drops Racial Fellowship Requirements Following Do No Harm Lawsuit


Declaring Victory Over Discrimination, Do No Harm Voluntarily Drops Suit Against Health Affairs

RICHMOND, Va., Jan. 22, 2024 /PRNewswire/ -- Today, Do No Harm announced it voluntarily dropped a lawsuit against Health Affairs' Health Equity Fellowship for Trainees after Health Affairs eliminated its discriminatory racial eligibility requirements.

In September 2022, Do No Harm filed a lawsuit on the grounds that the Health Affairs fellowship requirement was racially discriminatory against white students: Applicants were only eligible if they "identify as American Indian/Alaskan Native, African American/Black, Asian American, Native Hawaiian and other Pacific Islander, and Hispanic/Latino." While the lawsuit was pending, Health Affairs eliminated the unlawful requirement. As Health Affairs no longer considers race in the fellowship, Do No Harm voluntarily dismissed their lawsuit without prejudice.

"We are pleased that Health Affairs has decided to drop its racially discriminatory requirements for their fellowship," said Do No Harm Chairman Dr. Stanley Goldfarb. "Segregation based on race is illegal and Health Affairs has recognized that. Do No Harm will continue to fight divisive and discriminatory ideology in healthcare wherever we can find it."

The withdrawal filing can be found here: https://donoharmmedicine.org/wp-content/uploads/2024/01/DNH-v.-Health-Affairs-Notice-of-Voluntary-Dismissal.pdf
The original lawsuit can be found here: https://donoharmmedicine.org/2022/09/06/were-suing-health-affairs-for-racial-discrimination/

Do No Harm, established in April 2022, has rapidly gained recognition and made significant strides in its mission to safeguard healthcare from ideological threats. With more than 6,000 members, including doctors, nurses, physicians, and concerned citizens across all 50 states and in 14 countries, DNH has achieved more than 4,900 media hits in top-tier publications and garnered widespread attention through numerous broadcast news appearances.

SOURCE Do No Harm


These press releases may also interest you

at 03:05
Owkin, the first end-to-end AI-biotech unicorn that provides best-in-class AI-driven precision drug discovery, development and diagnostics, has announced its expansion into the DACH region (Germany, Austria and Switzerland) following partnerships...

at 03:05
We are excited to share our latest development status. We are pleased to announce that the enrollment of patients in the Phase III clinical trial of DFP-14323 in combination with Afatinib (20 mg/day) versus Afatinib (40 mg/day) alone in stage...

at 02:50
Two hospitals in Belgium are successfully live with the public cloud service from international medical imaging IT and cybersecurity company Sectra (STOCKHOLM: SECT-B). As the first to use Sectra One Cloud in the Benelux countries, the two hospitals...

at 02:03
Barrington James, a global leader in Life Science Recruitment, proudly announces the acquisition of S3 Science Recruitment, a firm renowned for its expertise in drug discovery, medical research, and the broader field of life sciences. Terms of the...

at 02:00
July 3, 2024 Amsterdam, the Netherlands ? Royal Philips , a global leader in health technology, today announced the appointment of Ms Ling Liu as the Chief Region Leader of Philips Greater China, effective immediately. Ms Liu is now a member of...

at 01:39
Hansa Biopharma, "Hansa" , will publish its interim report for January-June 2024 on July 18, 2024. Interested parties may join the Company's quarterly conference call on the same date at 14:00 CEST/8:00 AM EST. The event will be hosted by Søren...



News published on and distributed by: